⌘K

Login Start Free

Home/Filings/4/0001156039-25-000022

4//SEC Filing

BOUDREAUX GAIL 4

Accession 0001156039-25-000022

CIK 0001156039other

View on SEC.gov Company Profile

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 4:42 PM ET

Size

11.0 KB

Accession

0001156039-25-000022

Insider Transaction Report

Form 4

Period: 2025-03-03

Elevance Health, Inc.ELV

DirectorPresident and CEO

Transactions

Award
Common Stock
2025-03-03+10,620→ 126,933 total
Award
Common Stock
2025-03-03+15,587→ 142,520 total
Tax Payment
Common Stock
2025-03-03$395.50/sh−10,396$4,111,618→ 116,313 total
Award
Employee Stock Option (Right to Buy)
2025-03-03+40,429→ 40,429 total
Exercise: $395.50Exp: 2035-03-03→ Common Stock (40,429 underlying)

Holdings

Common Stock
(indirect: By Trust)
60

Footnotes (4)

[F1]PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
[F2]Represents restricted share units. Restrictions lapse as follows: 3,540 shares on 3/3/2026, 3/3/2027 and 3/3/2028.
[F3]Represents performance based restricted share units. Restrictions lapse on 3/3/2025.
[F4]The option represents a right to purchase a total of 40,429 shares, and is exercisable in three annual installments, with two installments of 13,476 shares each and one installment of 13,477 shares, beginning on 3/3/2026, which is the one-year anniversary of the option grant date.

Documents

1 file

4
wk-form4_1741210952.xmlPrimary
FORM 4

Issuer

Elevance Health, Inc.

CIK 0001156039

Entity typeother

Related Parties

1

filerCIK 0001287920

Filing Metadata

Form type: 4
Filed: Mar 4, 7:00 PM ET
Accepted: Mar 5, 4:42 PM ET
Size: 11.0 KB

View on SEC.gov